CROSS LINKED CHITOSAN IN SITU GEL OF SATRANIDAZOLE FOR INTRA PERIODONTAL DRUG DELIVERY
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2014, Vol 5, Issue 5
Abstract
This paper introduces a novel type of injectable temperature-sensitive chitosan polymer based in situ gel for the local delivery of Satranidazole into the infected periodontal pocket. The thermo gelling polymer, chitosan with different concentrations has been used for formulation of in situ gel of Satranidazole with 10 % propylene glycol as plasticizer and was allowed to cross linked with 1 % solution of glutaraldehyde for extended release. The FTIR studies and the XRD studies confirmed the absence of chemical interaction between the drug and the polymer. The developed formulations were evaluated for various parameters like surface pH, gelation temperature, drug content, spreadability, viscosity, in vitro drug release and in vitro antibacterial activity, SEM and stability studies. The optimized formulation G6 in terms of cumulative percent drug release along with zero order kinetic mechanism with 98.6 % drug release for 5 days and fulfilled many requirements of once a week delivery system. Throughout the permeation study, the average permeation rate for in situ gel was found to be above the minimum inhibitory concentration of Satranidazole indicating the suitability of formulating Satranidazole as a controlled release local delivery in situ gel for longer periods of time. Histopathological and microscopic study of the periodontal mucosa after permeation study suggested that the gel formulations were safe for local anti microbial treatment in to the infected periodontal pocket. The in vitro antibacterial activity demonstrated a significant antibacterial profile of the in situ gel G6 formulation against Porphyromonas gingivalis. The SEM of in situ gel suggesting that the drug(s) were dispersed rather than dissolved in the polymer matrix. The stability studies confirmed that the in situ gel formulation of Satranidazole remained stable at room temperature (30 ± 2°C) and refrigerator temperature (4 ± 2°C).
Authors and Affiliations
Revathy Nair, Sreeja Nair
Keywords
Related Articles
- EP ID EP94216
- DOI 10.7897/2230-8407.050580
- Views 95
- Downloads 0
INTERACTIVE POTENTIAL OF CLARITHROMYCIN IN RATS ADMINISTERED WITH GLICLAZIDE IN NORMAL AND DIABETIC CONDITIONS
To investigate the interaction between clarithromycin and gliclazide, the present study is designed in various animal models. Albino rats and rabbits were selected for the current study. The animals were suitably grouped...
INDUSTRIAL PROCESS VALIDATION OF SOLID DOSAGE FORMS: A REVIEW
Validation is one of the important steps in achieving and maintaining the quality of the final product. If each step of production process is validated we can assure that the final product is of the best quality. Validat...
PHARMACODYNAMIC INTERACTION OF GREEN TEA EXTRACT WITH HYDROCHLOROTHIAZIDE AGAINST ISOPROTERENOL INDUCED MYOCARDIAL DAMAGE IN RATS
To evaluate the pharmacodynamic interaction of green tea extract with hydrochlorothiazide against isoproterenol induced myocardial infarction wistar albino rat of either sex were prophylactically treated with hydrochloro...
PROTECTIVE EFFECT OF PARACALYX SCARIOSA (ROXB.) ALI AGAINST ETHANOL INDUCED HEPATIC TOXICITY IN BRL 3A CELL LINES
Paracalyx scariosa (Roxb.) Ali. is a woody twiners belongs to the family Fabaceae. The use of plant has been mentioned in folk medicine to treat liver disorders. The review has been reported the presence of flavonoids li...
METHOD DEVELOPMENT AND VALIDATION OF COMBINED TABLET DOSAGE FORM OF EMTRICITABINE AND TENOFOVIR DISPROXIL FUMERATE BY ULTRAVIOLET SPECTROSCOPY
In this study an attempt was made to provide newer simple, accurate and less time consuming Ultraviolet (UV) method for determination of Emtricitabine (EMT) and Tenofovir disproxil fumerate (TDF) in tablet dosage form. T...